Ironwood pharmaceuticals logo
WebApr 6, 2024 · 219. Free-Float. 97,9%. More Financials. Company. Ironwood Pharmaceuticals, Inc. is a gastrointestinal (GI) healthcare company, which is advancing the treatment of GI diseases and redefining the standard of care for GI patients. It is develops and commercializes GI product opportunities in areas of significant unmet need, leveraging its ... WebIronwood Pharmaceuticals Inc. Cl A company facts, information and financial ratios from MarketWatch. Ironwood Pharmaceuticals Inc. Cl A company facts, information and financial ratios...
Ironwood pharmaceuticals logo
Did you know?
Web1 day ago · Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the ... WebIronwood Pharmaceuticals Ironwood is dedicated to advancing the treatment of GI diseases and redefining the standard of care for millions of GI patients. Industry Biotechnology …
WebIronwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI … Mr. Emany has served as our chief financial officer since December 2024. Prior to … The Boston Globe named Ironwood Pharmaceuticals a Top Place to Work for … Our in-market product, LINZESS® (linaclotide), discovered in-house, is the … Ironwood Pharmaceuticals wants to make our careers website accessible to all … In November 2024 into a collaboration and license option agreement with COUR … Ironwood Pharmaceuticals. 100 Summer Street Suite 2300 Boston MA 02110. … Ironwood Pharmaceuticals is a patient-focused, biopharmaceutical company on … By providing your email address below, you are providing consent to Ironwood … One in five Americans suffer from GI diseases, resulting in millions of hospital … WebJan 9, 2024 · BOSTON, January 09, 2024--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today provided updated financial guidance for full year 2024 and announced financial ...
WebFeb 17, 2024 · Ironwood Pharmaceuticals Inc. reported fourth quarter revenue and adjusted earnings above analyst expectations. Fourth quarter total revenue came to $116.7 million, … WebMar 10, 2024 · Ironwood Pharmaceuticals has an overall rating of 3.7 out of 5, based on over 99 reviews left anonymously by employees. 69% of employees would recommend working at Ironwood Pharmaceuticals to a friend and 25% have a positive outlook for the business. This rating has decreased by -1% over the last 12 months.
WebApr 1, 2024 · – Ironwood capitalizing on GI leadership and expertise in an effort to bring innovative therapies to patients – – Strategy centered on accelerating LINZESS ® (linaclotide) growth and advancing late-stage programs IW-3718 and MD-7246 – – Business poised to drive revenue growth and begin generating profits – Ironwood Pharmaceuticals, …
WebMar 31, 2024 · Andrew Dreyfus joined our board of directors in April 2016. Mr. Dreyfus has served as president and chief executive officer for Blue Cross Blue Shield of Massachusetts, or BCBSMA, one of the largest Blue Cross Blue Shield insurance plans in the country, since 2010. From 2005 to 2010, Mr. Dreyfus served as the executive vice president of ... cswg team jobsWebFeb 17, 2024 · Ironwood Pharmaceuticals Inc. reported fourth quarter revenue and adjusted earnings above analyst expectations. Fourth quarter total revenue came to $116.7 million, down from $126.3 million a... earning customer trustWebMar 5, 2024 · For the twelve months ended December 31st, 2024 vs December 31st, 2016, Ironwood Pharmaceuticals reported revenue of $298.28MM vs $273.96MM (up 8.88%) and basic earnings per share -$0.78 vs -$0.56. earning cryptocurrency onlineWebJan 9, 2024 · Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) shares are trading lower by 10.00% to $11.30 Monday afternoon after the company cut its FY22 sales guidance below … earning customer serviceWebJan 4, 2024 · Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results February 13, 2024 Ironwood Pharmaceuticals Announces FDA Filing Acceptance and … earning crypto on coinbaseWebApr 10, 2024 · Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates … cswhap10WebIronwood Pharmaceuticals Inc. Cl A Watch list Create IRWD Alert Open Last Updated: Sep 9, 2024 12:27 p.m. EDT Real time quote $ 10.98 0.01 0.05% Previous Close $10.97 Advanced Charting Volume:... cswg webmail